After approving Bavarian Nordic’s mpox vaccine in September for use in adults, the World Health Organisation has given the vaccine the green light for use in adolescents aged 12 to 17 years. It comes as parts of Africa attempt to contain an uptick in cases of the disease.Read More
Bavarian Nordic mpox vaccine gets green light from WHO for use in adolescents
